TLRY
Tilray IncNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$734.37M
P/E Ratio
—
EPS
$-14.63
Beta
2.11
52W High
$23.20
52W Low
$3.50
50-Day MA
$6.97
200-Day MA
$9.77
Dividend Yield
—
Profit Margin
-156.70%
Forward P/E
1000.00
PEG Ratio
—
About Tilray Inc
Tilray Inc. is dedicated to the research, cultivation, production and distribution of medicinal cannabis and cannabinoids. The company is headquartered in Leamington, Canada.
Fundamentals
| Revenue (TTM) | $858.27M |
| Gross Profit (TTM) | $237.55M |
| EBITDA | $17.76M |
| Operating Margin | -52.70% |
| Return on Equity | -63.20% |
| Return on Assets | -1.47% |
| Revenue/Share (TTM) | $8.04 |
| Book Value | $3.02 |
| Price-to-Book | 0.50 |
| Price-to-Sales (TTM) | 0.86 |
| EV/Revenue | 1.027 |
| EV/EBITDA | -4.84 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -7.80% |
| Shares Outstanding | $119.60M |
| Float | $443.85M |
| % Insiders | 0.73% |
| % Institutions | 10.22% |
Historical Volatility
HV 10-Day
110.59%
HV 20-Day
86.93%
HV 30-Day
83.54%
HV 60-Day
67.68%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($10.04 target)
2
Buy7
Hold1
Strong SellData last updated: 4/30/2026